Literature DB >> 32247616

A circRNA derived from linear HIPK3 relieves the neuronal cell apoptosis in spinal cord injury via ceRNA pattern.

Jingwei Zhao1, Xi Qi1, Jingyu Bai2, Xiang Gao2, Liming Cheng3.   

Abstract

Spinal cord injury (SCI) is a severe disable symptom and has posed a great health threat to many people. Circ-HIPK3 has been reported to modulate the biological behavior of neuronal cells. Thence, in this study, we explored the mechanism of circ-HIPK3 in affecting functions of neuronal cell in SCI. SCI rat model was constructed to evaluate the apoptosis condition of spinal cord tissue. Meanwhile, 100 μM of CoCl2 was used to treat AGE1.HN and PC12 cells to induce in vitro SCI model. Functional assays were implemented to investigate the apoptosis of AGE1.HN and PC12 cells. RNase R and Act D treatment were both conducted to verify the circular character of circ-HIPK3. In this study, circ-HIPK3 was found lowly expressed in SCI rat models and AGE1.HN and PC12 cells induced by 100uM of CoCl2. Meanwhile, inhibited circ-HIPK3 or overexpressed circ-HIPK3 could separately elevate or reduce the apoptosis of AGE1.HN and PC12 cells. Moreover, circ-HIPK3 was identified as the ceRNA against miR-558 to up-regulate DPYSL5. Circ-HIPK3/miR-558/DPYSL5 axis modulated the apoptosis of AGE1.HN and PC12 cells in SCI. In conclusion, circ-HIPK3 relieves the neuronal cell apoptosis through regulating miR-588/DPYSL5 axis in SCI.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DPYSL5; Spinal cord injury; circ-HIPK3; miR-558

Year:  2020        PMID: 32247616     DOI: 10.1016/j.bbrc.2020.02.108

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  CircRNA3616 knockdown attenuates inflammation and apoptosis in spinal cord injury by inhibiting TLR4/NF-κB activity via sponging miR-137.

Authors:  Li Wang; Zhiwen Song; Hongjun Zou; Haining Chen; Yong Hu; Xiangnan Li; Jinbo Liu
Journal:  Mol Cell Biochem       Date:  2022-08-01       Impact factor: 3.842

2.  CircTYW1 serves as a sponge for microRNA-380 in accelerating neurological recovery following spinal cord injury via regulating FGF9.

Authors:  Yanpeng Sun; Yingjie Zhou; Xiangqin Shi; Xiaoran Ma; Xiaodong Peng; Yan Xie; Xiangyang Cao
Journal:  Cell Cycle       Date:  2021-08-10       Impact factor: 5.173

3.  Circular RNA CHST15 Sponges miR-155-5p and miR-194-5p to Promote the Immune Escape of Lung Cancer Cells Mediated by PD-L1.

Authors:  Jianru Yang; Yang Jia; Bing Wang; Shengrong Yang; Kun Du; Yujie Luo; Yunhe Li; Bing Zhu
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

Review 4.  The emerging role of circular RNAs in spinal cord injury.

Authors:  Hao Yu; Jingyuan Huang; Shengyu Yao; Cong Xing; Weixiao Liu; Bin Zhang; Shiqing Feng
Journal:  J Orthop Translat       Date:  2021-07-22       Impact factor: 5.191

Review 5.  Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity.

Authors:  Yuanyuan Zhang; Zhichen Tian; Haibo Ye; Xiaomei Sun; Huiming Zhang; Yujia Sun; Yongjiang Mao; Zhangping Yang; Mingxun Li
Journal:  Cell Death Discov       Date:  2022-05-20

Review 6.  An update on the roles of circular RNAs in spinal cord injury.

Authors:  Xuezhen Ma; Xuesong Wang; Xuexiao Ma; Xiugong Zhang; Xiaojin Gong; Ruifu Sun; Sunny H Wong; Matthew T V Chan; William Ka Kei Wu
Journal:  Mol Neurobiol       Date:  2022-02-03       Impact factor: 5.590

7.  circSPG21 protects against intervertebral disc disease by targeting miR-1197/ATP1B3.

Authors:  Yizhen Huang; Zhenlei Zhang; Jianle Wang; Shuying Shen; Teng Yao; Yining Xu; Zizheng Chen; Bin Fang; Jianjun Ma
Journal:  Exp Mol Med       Date:  2021-10-06       Impact factor: 8.718

Review 8.  Advancements in our understanding of circular and long non-coding RNAs in spinal cord injury.

Authors:  Yan Zhang; Ho Jun Yun; Yu Ji; Eric Cosky; Wen-Xiu Zhang; Wei Han; Yu-Chuan Ding
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.